Holger Huisman

Effect of linagliptin monotherapy on glycaemic control and markers of <i>β</i> ‐cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial

Stefano Del Prato, Anthony Barnett, Holger Huisman et al. · Diabetes Obesity and Metabolism · 2010 · 296 citations

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis

José M. Ferro, Jonathan M. Coutinho, Francesco Dentali et al. · JAMA Neurology · 2019 · 288 citations · Full text

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

F. Eskens, Constantijne H. Mom, André Planting et al. · British Journal of Cancer · 2007 · 230 citations · Full text

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Holger Huisman, Russell Jones et al. · The Lancet · 2013 · 178 citations

Metabolic Syndrome, Common Antidiabetes Treatments, Diabetes Management +9

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Bart C. Kuenen, Lee S. Rosen, Egbert F. Smit et al. · Journal of Clinical Oncology · 2002 · 128 citations

Solid Tumors, Medicine, Coagulation Cascade +10